VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 2 filers reported holding VBI VACCINES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $0 | – | 1,200 | -42.9% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 2,100 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 2,100 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 2,100 | -4.5% | 0.00% | – |
Q1 2022 | $1,000 | -66.7% | 2,200 | -69.4% | 0.00% | – |
Q4 2021 | $3,000 | -40.0% | 7,200 | +111.8% | 0.00% | – |
Q3 2021 | $5,000 | -44.4% | 3,400 | -81.7% | 0.00% | – |
Q2 2021 | $9,000 | -66.7% | 18,600 | +20.8% | 0.00% | -100.0% |
Q1 2021 | $27,000 | +350.0% | 15,400 | -16.3% | 0.00% | – |
Q4 2020 | $6,000 | -53.8% | 18,400 | -42.0% | 0.00% | – |
Q3 2020 | $13,000 | -23.5% | 31,700 | +19.2% | 0.00% | -100.0% |
Q2 2020 | $17,000 | +183.3% | 26,600 | +13.7% | 0.00% | – |
Q1 2020 | $6,000 | +100.0% | 23,400 | +249.3% | 0.00% | – |
Q4 2019 | $3,000 | – | 6,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
ArchPoint Investors | 65,000 | $202,000 | 0.06% |
FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
Ergoteles LLC | 171,127 | $532,000 | 0.02% |
J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |